1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Zirah, S. Kozin, S.A. Mazur, A.K. Blond, A. Cheminant, M. Segalas-Milazzo, I. Debey, P. Rebuffat, S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 281 2151 2161 10.1074/jbc.M504454200 16301322 Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging. 2006 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1984.093 16-mer from Alzheimer's disease amyloid Protein 1 syn polymer Alzheimer's disease amyloid A4 Protein, Amyloid beta A4 protein no yes (ACE)DAEFRHDSGYEVHHQK(NH2) XDAEFRHDSGYEVHHQKX A polypeptide(L) n n n n n n n n n n n n n n n n n n repository Initial release Version format compliance Version format compliance Database references 1 0 2005-05-03 1 1 2008-04-30 1 2 2011-07-13 1 3 2013-10-09 the same peptide in TFE/WATER 80/20 solution the same peptide complexed with a zinc (II) cation RCSB Y PDBJ 2005-04-18 REL REL This sequence occurs naturally in humans. sample This structure was determined using standard 2D homonuclear techniques target function 1000 20 DQF-COSY 2D TOCSY 2D NOESY HSQC HMBC 0.1 6.5 ambient 278 K the structures are based on a total of 206 restraints, 201 are NOE-derived distance constraints, 5 dihedral angle restraints simulated annealing 1 closest to the average 2.8mM in 50mM sodium phosphate buffer 90% H2O/10% D2O Bruker Biospin processing XWINNMR 3.1 Bruker Biospin data analysis AURELIA 1.6 Alexey K.Mazur structure solution ICMD 2.7 Alexey K.Mazur refinement ICMD 2.7 600 Bruker DMX ACE 0 n 1 ACE 0 A ASP 1 n 2 ASP 1 A ALA 2 n 3 ALA 2 A GLU 3 n 4 GLU 3 A PHE 4 n 5 PHE 4 A ARG 5 n 6 ARG 5 A HIS 6 n 7 HIS 6 A ASP 7 n 8 ASP 7 A SER 8 n 9 SER 8 A GLY 9 n 10 GLY 9 A TYR 10 n 11 TYR 10 A GLU 11 n 12 GLU 11 A VAL 12 n 13 VAL 12 A HIS 13 n 14 HIS 13 A HIS 14 n 15 HIS 14 A GLN 15 n 16 GLN 15 A LYS 16 n 17 LYS 16 A NH2 17 n 18 NH2 17 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 12 A A OD2 HG ASP SER 1 8 1.57 2 A ARG 5 0.132 SIDE CHAIN 1 A PHE 4 -143.92 51.33 1 A HIS 6 -144.16 14.89 2 A HIS 6 -141.50 12.63 5 A HIS 13 -137.09 -62.80 6 A ARG 5 -138.30 -46.70 7 A HIS 13 -131.62 -43.95 8 A HIS 13 -143.67 -51.73 13 A GLU 3 -87.14 41.85 13 A PHE 4 -83.63 48.79 16 A PHE 4 -143.68 25.23 17 A ASP 7 -134.51 -34.74 19 A PHE 4 -58.60 107.89 19 A HIS 13 -137.44 -51.38 20 A HIS 13 -137.63 -58.83 16-mer from Alzheimer's disease amyloid Protein Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in water solution at pH 6.5 1 N N A HIS 6 A HIS 7 HELX_P A TYR 10 A TYR 11 5 1 5 covale 1.325 A ACE 0 A C ACE 1 1_555 A ASP 1 A N ASP 2 1_555 covale 1.325 A LYS 16 A C LYS 17 1_555 A NH2 17 A N NH2 18 1_555 METAL BINDING PROTEIN irregular structure, METAL BINDING PROTEIN A4_HUMAN UNP 1 672 P05067 DAEFRHDSGYEVHHQK 672 687 1ZE7 1 16 P05067 A 1 2 17 1 ACETYLATION ACE 0 1ZE7 A P05067 UNP 1 1 AMIDATION NH2 17 1ZE7 A P05067 UNP 18 BINDING SITE FOR RESIDUE NH2 A 17 Software 2 A GLN 15 A GLN 16 2 1_555 A LYS 16 A LYS 17 2 1_555